Flagship Ventures Fund IV General Partner as of June 30, 2016
Portfolio Holdings for Flagship Ventures Fund IV General Partner
Flagship Ventures Fund IV General Partner holds 5 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seres Therapeutics (MCRB) | 63.0 | $368M | 13M | 29.05 | |
| Editas Medicine (EDIT) | 20.7 | $121M | 5.0M | 24.40 | |
| Syros Pharmaceuticals | 14.9 | $87M | 4.8M | 18.15 | |
| T2 Biosystems | 1.0 | $5.9M | 742k | 7.89 | |
| Eleven Biotherapeutics | 0.4 | $2.5M | 1.5M | 1.68 |
